Advancing toward an HIV-free future: the imperative of vaccine development
The adage ‘An ounce of prevention is worth a pound of cure’ rings true, especially in the context of a widespread epidemic like HIV/AIDS. Despite the challenges inherent in its implementation, the urgency for comprehensive prevention and treatment strategies remains undeniable in our pursuit of an HIV-free future. The Global HIV/AIDS Epidemic The gl
Avian Influenza virus infections in human
The CDC recently reported four human infections with the highly pathogenic avian influenza (HPAI) A (H5N1) virus in Cambodia, with a mortality rate of 25%. There is no evidence of person-to-person transmission, and all patients were shown to have had recent exposure to sick or dead poultry. Different organizations are collaborating in a One Health […]
Pediatric Flu deaths in America
On March 8th, a CDC report declared that there have been 103 flu-related pediatric deaths in the 2023-2024 season in America. This data highlights the importance of the seasonal flu vaccination for all ages, and it emphasizes the necessity for research into the development of a ‘universal flu vaccine’ to ensure full protection. The concept […
The 31st annual CROI (Conference on Retroviruses and Opportunistic Infections)
At the beginning of March, the 31st annual CROI, a prominent congress in the field of HIV research, was held in Denver. Notably, one of the engaging oral abstract sessions centered around HIV Immunology and Vaccines. The Bernard Field Lecture, delivered by Professor Barney Graham, former deputy director of the Vaccine Research Center (VRC), was […]
Flu Project
Cloning and characterization of two heterosubtypic neutralizing antibodies crucial for further vaccine approaches.
HCV Project
Cloning and characterization of two neutralizing antibodies, laying the foundation for an innovative HCV vaccine.
HIV Project
Proof of concept vaccine development through the revolutionary concept of anti-idiotype (AI) antibodies.
JCV Project
Cloning and characterization of the first human neutralizing antibody, propelling it towards clinical exploration.
